K182593

Substantially Equivalent

KET-1 Blood Ketone Monitoring System

Applicant: Apex BioTechnology Corp.
Product code: JIN
Advisory panel: Clinical Chemistry
Date received: 2018-09-20
Decision date: 2018-12-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hsinchu, TW

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.